Hologram QSAR Studies on Farnesoid X Receptor Activators

Title: Hologram QSAR Studies on Farnesoid X Receptor Activators

Volume: 3 Issue: 4

Author(s): Kathia M. Honorio, Richard C. Garratt, Igor Polikarpov and Adriano D. Andricopulo

Affiliation:

Keywords: HQSAR, drug design, FXR, medicinal chemistry, cholesterol

Abstract: Farsenoid X receptor (FXR) is an attractive drug target due to its role in the regulation of cholesterol and bile acid levels. Hologram quantitative structure-activity relationships (HQSAR) were conducted on a series of FXR activators, and the final model obtained was used to predict the potency of 10 test set compounds. The predicted values were in good agreement with the experimental results.

Cite this article as:

Honorio M. Kathia, Garratt C. Richard, Polikarpov Igor and Andricopulo D. Adriano, Hologram QSAR Studies on Farnesoid X Receptor Activators, Letters in Drug Design & Discovery 2006; 3 (4) . https://dx.doi.org/10.2174/157018006776743206